COUR NanoParticle technology halts Type 1 diabetes progression
COUR Pharmaceuticals has published details of a study with the Miller Lab at Northwestern University, in which treatment with the COUR NanoParticle Platform (CNP) prevented
COUR Pharmaceuticals has published details of a study with the Miller Lab at Northwestern University, in which treatment with the COUR NanoParticle Platform (CNP) prevented
Sanofi and Roche have joined forces in France to drive adoption of a connected add-on for disposable insulin pens. The partners will jointly develop a
A set of policy recommendations have been drafted by the European Diabetes Forum (EUDF), emphasising the importance of digitalisation, data registries and integrated care to
The Diabetes Research & Wellness Foundation (DRWF) has announced that its fourth annual Diabetes Wellness Day Midlands will be held on 24th September at Chesford
Australia could become the first country to adopt routine childhood screening to detect Type 1 diabetes in children, if a new national screening research pilot
A recent study has found that low serum levels of vitamin D were significantly associated with a higher prevalence of diabetic foot ulcers (DFUs) in
Type 2 diabetes is a well-established risk factor for dementia and Parkinson’s Disease (PD), but according to a report by Marlene Busko in Medscape, a
New legislation to allow a wider range of healthcare professionals to certify so-called ‘fit notes’ has been laid before the UK Parliament. From 1 July
Diabetic macular oedema (DME) is one of the most common diabetes-related eye complications and causes of vision loss (c12% of people with Type 1 and
Following new guidelines from the National Institute for Care and Excellence (NICE) which recommends that adults with Type 1 diabetes should be offered a choice